TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 95 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,000 | -69.9% | 53,080 | +128.1% | 0.00% | -100.0% |
| Q2 2018 | $83,000 | -82.0% | 23,273 | -68.2% | 0.00% | -87.5% |
| Q4 2017 | $460,000 | +114.0% | 73,076 | +132.0% | 0.01% | +100.0% |
| Q3 2017 | $215,000 | -47.7% | 31,497 | -45.4% | 0.00% | -50.0% |
| Q2 2017 | $411,000 | +263.7% | 57,663 | +369.5% | 0.01% | +166.7% |
| Q1 2017 | $113,000 | +36.1% | 12,283 | -40.5% | 0.00% | 0.0% |
| Q4 2016 | $83,000 | -69.6% | 20,652 | -65.0% | 0.00% | -85.7% |
| Q1 2016 | $273,000 | +6.2% | 58,931 | +129.2% | 0.02% | -25.0% |
| Q4 2015 | $257,000 | – | 25,709 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |